Trade Summary

5 days ago, Berns Paul L, serving as See Remarks at Neumora Therapeutics, Inc. (NMRA), sold 9,819 shares at $3.51 per share, for a total transaction value of $34,459.00. Following this transaction, Berns Paul L now holds 7,794,476 shares of NMRA.

The trade was executed on Tuesday, February 17, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 19, 2026, 2 days after the trade was made.

Neumora Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.